Physician profile
William R Post
NPI 1679589196
$3,649.55
in general payments reported to CMS, 2019-2025
14 companies · $25.40 in 2025
The $25.40 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $758 · 2021: $2,489 · 2022: $167 · 2023: $35.92 · 2024: $16.48 · 2025: $25.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $3,176.71 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $110.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $94.82 | 2019 | |
| Depuy Synthes Sales INC. | $75.60 | 2019-2021 | |
| Bioventus LLC | $28.99 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $28.32 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.40 | 2025 | Exparel, Iovera |
| Stryker Corporation | $22.04 | 2023 | Mako |
| Baudax Bio INC. | $18.79 | 2021 | |
| Avanos Medical | $15.81 | 2022 | |
| Endo Pharmaceuticals INC. | $15.72 | 2022 | |
| Pacira Therapeutics, INC. | $13.22 | 2019 | |
| Fidia Pharma USA INC. | $12.51 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.